(Q46552808)

23 December 2017

title

Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth (English)

1 reference

23 December 2017

0 references

Greenman Y

1

1 reference

23 December 2017

Tordjman K

2

1 reference

23 December 2017

Osher E

3

1 reference

23 December 2017

Veshchev I

4

1 reference

23 December 2017

Shenkerman G

5

1 reference

23 December 2017

Reider-Groswasser II

6

1 reference

23 December 2017

Segev Y

7

1 reference

23 December 2017

Ouaknine G

8

1 reference

23 December 2017

Stern N

9

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

published in

Clinical Endocrinology

1 reference

23 December 2017

volume

63

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

39-44

1 reference

23 December 2017

Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Diagnosis and management of nonfunctioning pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Minor tumour shrinkage in nonfunctioning pituitary adenomas by long-term treatment with the dopamine agonist cabergoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Combined beta FSH and beta LH response to TRH in patients with clinically non-functioning pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02295.X

10.1111/J.1365-2265.2005.02295.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017